concept

PARP inhibitors

Also known as: PARP inhibitor, PARP inhibition

Facts (2)

Sources

The Biological Basis for Women's Health Through the Lens of ... - NCBI ncbi.nlm.nih.gov Geller A, Salganicoff A, Burke SP · National Academies Press 1 fact

measurementThe FDA approved olaparib, the first PARP inhibitor, in 2014 for patients with advanced ovarian cancers harboring BRCA mutations.

10 Breakthrough Research and Clinical Trials Shaping the ... honcology.com HOncology Dec 29, 2025 1 fact

claimHirschfeld Oncology utilizes molecular profiling to direct the use of targeted therapies, such as PARP inhibitors like Olaparib, for patients with specific genetic subgroups.